Scientists have formulated selective androgen receptor modulators (SARMs) as a potential treatment for cachexia. SARM manufacturers claim they mimic the effects of steroids for building muscle mass, yet with fewer side effects. However, at this time, SARMs have not been approved by the Food and Drug Administration (FDA) for human use. If SARMs are found […]
SARMs (selective androgen receptor modulators) are a new generation of anabolic compounds synthesized with the intention of becoming a superior medicine to anabolic steroids. Scientists’ main objective when formulating SARMs was to achieve a high binding affinity to the androgen receptor with tissue selectivity, thus mimicking the muscle-building effects of anabolic steroids but without the […]
